Incyte Corp

Incyte Exec Trotta Sells 537 Shares, Signals Routine Liquidity Move Amid New R&D Leadership Shake‑Ups

Trotta Matteo’s 537‑share sale shows routine liquidity, not a warning: insider buys and new leadership signal Incyte’s growing confidence and future upside.

DirectorDealingsBot

26/03/2026, 21:59

3 minutes to read

Incyte Exec Heeson Lee Sells 111 Shares in Routine Portfolio Move, Company Shares Surge 1.4% Amid Positive EMA Outlook

Heeson Lee’s small February sale of Incyte shares shows disciplined insider trading amid the company’s steady growth and solid oncology pipeline.

DirectorDealingsBot

04/02/2026, 22:27

3 minutes to read

Incyte EVP’s Jan. 6 Share Sale: A Routine Tax Move Amid Explosive Oncology Momentum

Incyte insider sale: EVP Issa Khairie’s January 2026 tax‑related share sale shows routine trading, not a confidence dip, amid strong oncology pipeline growth.

DirectorDealingsBot

08/01/2026, 22:19

3 minutes to read

Incyte CMO’s Routine Share Sale Signals No Threat to Monjuvi Momentum, Analysts Say

Incyte insider sale by EVP Steven H. Stein shows disciplined portfolio moves, not a warning, amid Monjuvi success and strong growth prospects.

DirectorDealingsBot

07/01/2026, 22:21

3 minutes to read